尿嘧啶DNA糖基化酶在免疫球蛋白基因多样化中存在争议的作用。
The contested role of uracil DNA glycosylase in immunoglobulin gene diversification.
作者信息
Longerich Simonne, Storb Ursula
机构信息
Department of Molecular Genetics and Cell Biology, Committee on Immunology, University of Chicago, IL 60637, USA.
出版信息
Trends Genet. 2005 May;21(5):253-6. doi: 10.1016/j.tig.2005.02.013.
Class switch recombination (CSR) and somatic hypermutation (SHM) of immunoglobulin (Ig) genes are initiated by the activation-induced cytosine deaminase AID. The resulting uracils in Ig genes were believed to be removed by the uracil glycosylase (UNG) and the resulting abasic sites treated in an error-prone fashion, creating breaks in the Ig switch regions and mutations in the variable regions. A recent report suggests that UNG does not act as a glycosylase in CSR and SHM but rather has unknown activity subsequent to DNA breaks that were created by other mechanisms.
免疫球蛋白(Ig)基因的类别转换重排(CSR)和体细胞超突变(SHM)由激活诱导的胞嘧啶脱氨酶AID启动。Ig基因中产生的尿嘧啶被认为由尿嘧啶糖基化酶(UNG)去除,产生的无碱基位点以易错方式处理,从而在Ig转换区产生断裂并在可变区产生突变。最近的一份报告表明,UNG在CSR和SHM中并非作为糖基化酶起作用,而是在由其他机制产生的DNA断裂后具有未知活性。